By Benjamin Waldrum

May 20, 2021 | LITTLE ROCK — The Paula and Rodger Riney Foundation announced a gift of $1.8 million to the University of Arkansas for Medical Sciences (UAMS) Myeloma Center in the Winthrop P. Rockefeller Cancer Institute to fund multiple myeloma research.

“Paula and I are pleased to invest in the UAMS Myeloma Center, which has made great strides in advancing multiple myeloma research and increasing survival rates,” Rodger Riney said. “As a multiple myeloma patient, I understand the critical need to pursue new research and treatments, in hopes of ultimately finding a cure.”

Rodger Riney is the former founder and CEO of the discount brokerage firm Scottrade. He was diagnosed with multiple myeloma in 2015 and has since become an advocate for research and treatment of the disease, including serving on the board of directors for the Multiple Myeloma Research Foundation.

https://news.uams.edu/2021/05/20/riney-foundation-gives-1-8-million-to-uams-myeloma-center-in-the-winthrop-p-rockefeller-cancer-institute/

The Paula and Rodger Riney Foundation's gift will support multiple myeloma research at the UAMS Myeloma Center. Image by Courtesy Paula and Rodger Riney Foundation — The Paula and Rodger Riney Foundation's gift will support multiple myeloma research at the UAMS Myeloma Center. ***Image by Courtesy Paula and Rodger Riney Foundation***

A researcher with the University of Arkansas for Medical Sciences will use a $1.7 million grant to find new ways to treat a deadly blood disorder.

The grant from the National Cancer Institute is going to Dr. Jesus Delgado-Calle, assistant professor of physiology and biophysics at UAMS, who is studying ways to improve bone health to prevent or delay relapses in patients with multiple myeloma.

https://www.ualrpublicradio.org/post/17-million-grant-fund-uams-myeloma-research

$1.7 Million Grant To Fund UAMS Myeloma Research
A researcher with the University of Arkansas for Medical Sciences will use a $1.7 million grant to find new ways to treat a deadly blood disorder. The grant from the National Cancer Institute is going to Dr. Jesus Delgado-Calle, assistant professor of physiology and biophysics at UAMS, who is studying ways to improve bone health to prevent or delay relapses in patients with multiple myeloma.